US Stock MarketDetailed Quotes

OSCR Oscar Health

Watchlist

14.350
+0.800+5.90%

Close Jan 3 16:00 ET

14.900
+0.550+3.83%

Pre 06:40 ET

3.55BMarket Cap-717.50P/E (TTM)

Oscar Health Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Oscar Health Q3 2024 Earnings Date

Currency：USDNov 7, 2024

	Estimate (YoY)	Actual (YoY)	Vs Estimate (% Chg)
Revenue	2.35B	2.42B	+77.56M
Beat Est.	+62.75%	+68.30%	+3.31%
EPS	-0.20	-0.22	-0.02
Miss Est.	+31.74%	+24.14%	-11.17%

Analyst Rating

Hold

Dec 31, 2024

Oscar Health Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q1	-- / 2.792B	--
--	2024/Q4	-- / 2.472B	--
Nov 7, 2024	2024/Q3	2.423B / 2.346B	--
Aug 7, 2024	2024/Q2	2.219B / 2.171B	--
May 7, 2024	2024/Q1	2.142B / 1.993B	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q1-- / 2.792B--

--2024/Q4-- / 2.472B--

Nov 7, 20242024/Q32.423B / 2.346B--

Aug 7, 20242024/Q22.219B / 2.171B--

May 7, 20242024/Q12.142B / 1.993B--

Unlock Free Earnings Estimates

Open Account

Oscar Health Earnings Reports

Oscar Health | 10-Q: Q3 2024 Earnings Report

Nov 7, 2024 16:19 ET

Oscar Health | 8-K: Oscar Health Announces Results for Third Quarter 2024 November 7, 2024

Nov 7, 2024 06:13 ET

Oscar Health | 10-Q: Q2 2024 Earnings Report

Aug 7, 2024 16:18 ET

Oscar Health | 8-K: Oscar Health Announces Results for Second Quarter 2024 and Raises Full Year Revenue and Adjusted EBITDA Outlook August 7, 2024

Aug 7, 2024 06:06 ET

Trending US Stocks

Symbol Mini Chart % Chg

DexCom

DXCM

+3.27%

Collegium Pharmaceutical

Unlock the Full List

Analysis

Analyst Rating

Updated: Dec 31, 2024

Hold

Buy
60.00%
Hold
0.00%
Sell
40.00%

Price Target

No Data